CompletedNot Applicable

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis

China50 participantsStarted 2022-08-03

Plain-language summary

The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectiveness and safety of cold atmospheric plasma on Malassezia folliculitis. Participants entered this double-blind placebo-controlled trial will randomly assign to treatment with either cold atmospheric plasma or antifungal drugs. The differences of treatment effects of the two groups will be observed and compared.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients are clinical presentation of Malassezia folliculitis in seborrheic areas. * The diagnoses are mycologically verified by experienced laboratory technicians. * Participants must be informed of the investigational nature of this study and be willing to provide written informed consent. Exclusion Criteria: * Combined with other serious systemic diseases. * History of topical corticosteroids within 2 weeks or history of systemic corticosteroids within 1 month. * History of immunosuppressive drugs within 1 month. * History of topical antifungal medication within 2 weeks or systemic antifungal medication within 3 months. * Pregnant and lactating women.

What they're measuring

50% reduction in number of lesion

Timeframe: week 2

Trial details

NCT IDNCT04886323

SponsorThe Second Hospital of Anhui Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-17

View on ClinicalTrials.gov More Malassezia Folliculitis trials